Published in Sci Rep on November 10, 2011
Management of Kawasaki disease. Arch Dis Child (2013) 2.30
Tropospheric winds from northeastern China carry the etiologic agent of Kawasaki disease from its source to Japan. Proc Natl Acad Sci U S A (2014) 0.97
Seasonality of Kawasaki disease: a global perspective. PLoS One (2013) 0.97
Population-based study of the association between urbanization and Kawasaki disease in Taiwan. ScientificWorldJournal (2013) 0.96
Infectious disease: Blowing in the wind. Nature (2012) 0.89
Evaluation of the Temporal Association between Kawasaki Disease and Viral Infections in South Korea. Korean Circ J (2014) 0.88
Kawasaki disease-specific molecules in the sera are linked to microbe-associated molecular patterns in the biofilms. PLoS One (2014) 0.86
Data-driven discovery of seasonally linked diseases from an Electronic Health Records system. BMC Bioinformatics (2014) 0.84
Infection surveillance after a natural disaster: lessons learnt from the Great East Japan Earthquake of 2011. Bull World Health Organ (2013) 0.81
Finding Kawasaki disease. Ann Pediatr Cardiol (2012) 0.79
A combination of cross correlation and trend analyses reveals that Kawasaki disease is a pollen-induced delayed-type hyper-sensitivity disease. Int J Environ Res Public Health (2014) 0.78
Diagnostic approach and current treatment options in childhood vasculitis. Turk Pediatri Ars (2015) 0.77
Kawasaki disease: a matter of innate immunity. Clin Exp Immunol (2016) 0.77
Decreasing fertility rate correlates with the chronological increase and geographical variation in incidence of Kawasaki disease in Japan. PLoS One (2013) 0.77
Ethnic Kawasaki Disease Risk Associated with Blood Mercury and Cadmium in U.S. Children. Int J Environ Res Public Health (2016) 0.76
Kawasaki disease for dermatologists. Indian Dermatol Online J (2016) 0.76
Ambient Air Pollutant Exposures and Hospitalization for Kawasaki Disease in Taiwan: A Case-Crossover Study (2000-2010). Environ Health Perspect (2016) 0.75
Variations in the structure of airborne bacterial communities in Tsogt-Ovoo of Gobi desert area during dust events. Air Qual Atmos Health (2016) 0.75
Adult Kawasaki disease in a European patient: a case report and review of the literature. J Med Case Rep (2015) 0.75
Predicting the characteristics of the aetiological agent for Kawasaki disease from other paediatric infectious diseases in Japan. Epidemiol Infect (2015) 0.75
A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics (1974) 9.97
Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Circulation (1996) 7.29
Kawasaki syndrome. Lancet (2004) 5.09
The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med (1986) 4.49
Atmospheric movement of microorganisms in clouds of desert dust and implications for human health. Clin Microbiol Rev (2007) 4.16
ENSO and cholera: a nonstationary link related to climate change? Proc Natl Acad Sci U S A (2002) 3.45
Nationwide survey of Kawasaki disease and acute rheumatic fever. J Pediatr (1991) 2.82
Epidemiologic features of Kawasaki disease in Japan: results from the nationwide survey in 2005-2006. J Epidemiol (2008) 2.36
Increasing springtime ozone mixing ratios in the free troposphere over western North America. Nature (2010) 2.17
Impact of atmospheric dispersion and transport of viral aerosols on the epidemiology of influenza. Rev Infect Dis (1989) 2.04
Kawasaki disease: what is the epidemiology telling us about the etiology? Int J Infect Dis (2005) 1.93
Increasing incidence of Kawasaki disease in Japan: nationwide survey. Pediatr Int (2008) 1.90
Seasonality and temporal clustering of Kawasaki syndrome. Epidemiology (2005) 1.59
Searching for the cause of Kawasaki disease--cytoplasmic inclusion bodies provide new insight. Nat Rev Microbiol (2008) 1.56
Coronary arterial lesions of Kawasaki disease: cardiac catheterization findings of 1100 cases. Pediatr Cardiol (1986) 1.50
Short-term weather variability in Chicago and hospitalizations for Kawasaki disease. Epidemiology (2009) 1.46
Ambient influenza and avian influenza virus during dust storm days and background days. Environ Health Perspect (2010) 1.31
Kawasaki syndrome in Hawaii. Pediatr Infect Dis J (2005) 1.24
Ultrastructural, immunofluorescence, and RNA evidence support the hypothesis of a "new" virus associated with Kawasaki disease. J Infect Dis (2011) 1.12
Nationwide survey on Kawasaki disease in Japan. Pediatrics (1987) 1.09
Finding the cause of Kawasaki disease: a pediatric infectious diseases research priority. J Infect Dis (2006) 1.09
Spatial and temporal clustering of Kawasaki syndrome cases. Pediatr Infect Dis J (2008) 1.05
Mortality among persons with a history of Kawasaki disease in Japan: existence of cardiac sequelae elevated the mortality. J Epidemiol (2000) 0.86
Diagnostic criteria, clinical features, and incidence of thyroid storm based on nationwide surveys. Thyroid (2012) 2.78
ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms. Nat Genet (2007) 2.77
A genome-wide association study identifies novel and functionally related susceptibility Loci for Kawasaki disease. PLoS Genet (2009) 2.45
Resistance to intravenous immunoglobulin in children with Kawasaki disease. J Pediatr (2008) 2.44
Epidemiologic features of Kawasaki disease in Japan: results from the nationwide survey in 2005-2006. J Epidemiol (2008) 2.36
Altered expression profiles of microRNAs during TPA-induced differentiation of HL-60 cells. Biochem Biophys Res Commun (2004) 2.31
Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition). Pediatr Int (2005) 2.30
Infliximab treatment for refractory Kawasaki syndrome. J Pediatr (2005) 2.21
Epidemiologic features of Kawasaki disease in Japan: results of the 2009-2010 nationwide survey. J Epidemiol (2012) 2.15
Epidemiologic features of Kawasaki disease in Japan: results of the 2007-2008 nationwide survey. J Epidemiol (2010) 2.09
Genome-wide association study identifies FCGR2A as a susceptibility locus for Kawasaki disease. Nat Genet (2011) 1.97
Increasing incidence of Kawasaki disease in Japan: nationwide survey. Pediatr Int (2008) 1.90
When children with Kawasaki disease grow up: Myocardial and vascular complications in adulthood. J Am Coll Cardiol (2009) 1.88
Prevalence of Kawasaki disease in young adults with suspected myocardial ischemia. Circulation (2012) 1.82
Crystal structure and functional analysis of the eukaryotic class II release factor eRF3 from S. pombe. Mol Cell (2004) 1.81
The long noncoding RNA THRIL regulates TNFα expression through its interaction with hnRNPL. Proc Natl Acad Sci U S A (2013) 1.78
Prevalence of coronary artery abnormality in incomplete Kawasaki disease. Pediatr Int (2007) 1.72
Incidence of Kawasaki disease in Japan: the nationwide surveys of 1999-2002. Pediatr Int (2006) 1.69
Infliximab treatment of intravenous immunoglobulin-resistant Kawasaki disease. J Pediatr (2008) 1.63
Early intravenous gamma-globulin treatment for Kawasaki disease: the nationwide surveys in Japan. J Pediatr (2004) 1.59
A genome-wide association study identifies three new risk loci for Kawasaki disease. Nat Genet (2012) 1.58
Structural insights into eRF3 and stop codon recognition by eRF1. Genes Dev (2009) 1.57
Phosphoinositide 3-kinase signaling pathway mediated by p110α regulates invadopodia formation. J Cell Biol (2011) 1.56
Point-of-care differentiation of Kawasaki disease from other febrile illnesses. J Pediatr (2012) 1.55
Coronary artery lesions of incomplete Kawasaki disease: a nationwide survey in Japan. Eur J Pediatr (2011) 1.52
Frequency of drug-resistant viruses and virus shedding in pediatric influenza patients treated with neuraminidase inhibitors. Clin Infect Dis (2011) 1.52
Low plasma D-dimer concentration predicts the absence of traumatic brain injury in children. J Trauma (2010) 1.50
Impressions of Kawasaki syndrome in India. Indian Pediatr (2006) 1.47
Recombinant phospholipase Czeta has high Ca2+ sensitivity and induces Ca2+ oscillations in mouse eggs. J Biol Chem (2003) 1.46
Transforming growth factor-beta signaling pathway in patients with Kawasaki disease. Circ Cardiovasc Genet (2010) 1.45
Lipid rafts and caveolin-1 are required for invadopodia formation and extracellular matrix degradation by human breast cancer cells. Cancer Res (2009) 1.42
Gene-expression patterns reveal underlying biological processes in Kawasaki disease. Genome Biol (2007) 1.39
Descriptive epidemiology of Kawasaki disease in Japan, 2011-2012: from the results of the 22nd nationwide survey. J Epidemiol (2015) 1.39
Bass hepcidin is a novel antimicrobial peptide induced by bacterial challenge. Eur J Biochem (2002) 1.37
Infliximab for intravenous immunoglobulin resistance in Kawasaki disease: a retrospective study. J Pediatr (2010) 1.34
Performance of 2004 American Heart Association recommendations for treatment of Kawasaki disease. Pediatrics (2010) 1.33
The critical role of the universally conserved A2602 of 23S ribosomal RNA in the release of the nascent peptide during translation termination. Mol Cell (2003) 1.32
A genomewide linkage analysis of Kawasaki disease: evidence for linkage to chromosome 12. J Hum Genet (2006) 1.30
Omnipotent decoding potential resides in eukaryotic translation termination factor eRF1 of variant-code organisms and is modulated by the interactions of amino acid sequences within domain 1. Proc Natl Acad Sci U S A (2002) 1.28
A novel phospholipase C, PLC(eta)2, is a neuron-specific isozyme. J Biol Chem (2005) 1.28
Discovery and characterization of two isoforms of moronecidin, a novel antimicrobial peptide from hybrid striped bass. J Biol Chem (2001) 1.26
RNA aptamers to initiation factor 4A helicase hinder cap-dependent translation by blocking ATP hydrolysis. RNA (2003) 1.23
Phospholipase C is a key enzyme regulating intracellular calcium and modulating the phosphoinositide balance. Prog Lipid Res (2010) 1.23
Kawasaki disease: late cardiovascular sequelae. Curr Opin Cardiol (2012) 1.21
A diagnostic algorithm combining clinical and molecular data distinguishes Kawasaki disease from other febrile illnesses. BMC Med (2011) 1.21
Common variants in CASP3 confer susceptibility to Kawasaki disease. Hum Mol Genet (2010) 1.20
New Japanese neonatal anthropometric charts for gestational age at birth. Pediatr Int (2014) 1.18
Recognition of a Kawasaki disease shock syndrome. Pediatrics (2009) 1.17
Failure to diagnose Kawasaki disease at the extremes of the pediatric age range. Pediatr Infect Dis J (2004) 1.17
Selection of RNA aptamers against recombinant transforming growth factor-beta type III receptor displayed on cell surface. Biochimie (2006) 1.16
Channel mutations in Hsp104 hexamer distinctively affect thermotolerance and prion-specific propagation. Mol Microbiol (2007) 1.15
Reliability and validity of the Japanese version of the Resilience Scale and its short version. BMC Res Notes (2010) 1.13
RNA aptamers selected against the receptor activator of NF-kappaB acquire general affinity to proteins of the tumor necrosis factor receptor family. Nucleic Acids Res (2004) 1.12
Memory T-cells and characterization of peripheral T-cell clones in acute Kawasaki disease. Autoimmunity (2010) 1.12
[PHI+], a novel Sup35-prion variant propagated with non-Gln/Asn oligopeptide repeats in the absence of the chaperone protein Hsp104. Genes Cells (2003) 1.12
Late intravenous immunoglobulin treatment in patients with Kawasaki disease. Pediatrics (2012) 1.12
Differential expression of miR-145 in children with Kawasaki disease. PLoS One (2013) 1.12
Monthly observation of the number of patients with Kawasaki disease and its incidence rates in Japan: chronological and geographical observation from nationwide surveys. J Epidemiol (2008) 1.11
Older age is a risk factor for the development of cardiovascular sequelae in Kawasaki disease. Pediatrics (2004) 1.11
The role of EF-hand domains and C2 domain in regulation of enzymatic activity of phospholipase Czeta. J Biol Chem (2005) 1.09
Use of laboratory data to identify risk factors of giant coronary aneurysms due to Kawasaki disease. Pediatr Int (2004) 1.08
The impact of future summer temperature on public health in Barcelona and Catalonia, Spain. Int J Biometeorol (2012) 1.08
Polypeptide release at sense and noncognate stop codons by localized charge-exchange alterations in translational release factors. Proc Natl Acad Sci U S A (2002) 1.07
Delayed diagnosis by physicians contributes to the development of coronary artery aneurysms in children with Kawasaki syndrome. Pediatr Infect Dis J (2007) 1.07
Inhibition of midkine alleviates experimental autoimmune encephalomyelitis through the expansion of regulatory T cell population. Proc Natl Acad Sci U S A (2008) 1.07
Spatial and temporal clustering of Kawasaki syndrome cases. Pediatr Infect Dis J (2008) 1.05
Elongation factor G participates in ribosome disassembly by interacting with ribosome recycling factor at their tRNA-mimicry domains. Mol Cell (2002) 1.05
Nationwide survey of patients in Japan with Bickerstaff brainstem encephalitis: epidemiological and clinical characteristics. J Neurol Neurosurg Psychiatry (2012) 1.05
Coronary artery outcomes among children with Kawasaki disease in the United States and Japan. Int J Cardiol (2013) 1.05
Case-control study of giant coronary aneurysms due to Kawasaki disease. Pediatr Int (2003) 1.04
Phosphatidylinositol 4,5-bisphosphate and PIP5-kinase Ialpha are required for invadopodia formation in human breast cancer cells. Cancer Sci (2010) 1.04
Familial Mediterranean fever in Japan. Medicine (Baltimore) (2012) 1.04
Structural and molecular basis for hyperspecificity of RNA aptamer to human immunoglobulin G. RNA (2008) 1.04
Evolution of laboratory values in patients with Kawasaki disease. Pediatr Infect Dis J (2011) 1.03
A regulatory role of the Rnq1 nonprion domain for prion propagation and polyglutamine aggregates. Mol Cell Biol (2008) 1.03
Reply to: "Experimental aspects of copy number variant assays at CCL3L1". Nat Med (2009) 1.03
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association. Circulation (2017) 1.02
trans-Resveratrol, a natural antioxidant from grapes, increases sperm output in healthy rats. J Nutr (2005) 1.00
Replication and meta-analysis of GWAS identified susceptibility loci in Kawasaki disease confirm the importance of B lymphoid tyrosine kinase (BLK) in disease susceptibility. PLoS One (2013) 0.99
Cost of depression among adults in Japan in 2005. Psychiatry Clin Neurosci (2011) 0.99
Conformational plasticity of RNA for target recognition as revealed by the 2.15 A crystal structure of a human IgG-aptamer complex. Nucleic Acids Res (2010) 0.99
Gene transcript abundance profiles distinguish Kawasaki disease from adenovirus infection. J Infect Dis (2009) 0.99
Lymph-node-first presentation of Kawasaki disease compared with bacterial cervical adenitis and typical Kawasaki disease. J Pediatr (2013) 0.99
Calcineurin inhibitor treatment of intravenous immunoglobulin-resistant Kawasaki disease. J Pediatr (2012) 0.98
High affinity RNA for mammalian initiation factor 4E interferes with mRNA-cap binding and inhibits translation. RNA (2005) 0.98
Therapeutic potential of anti-interleukin-17A aptamer: suppression of interleukin-17A signaling and attenuation of autoimmunity in two mouse models. Arthritis Rheum (2011) 0.98
Incidence of Kawasaki disease in northern European countries. Pediatr Int (2012) 0.98
Cardiovascular biomarkers in acute Kawasaki disease. Int J Cardiol (2011) 0.98
Seasonality of Kawasaki disease: a global perspective. PLoS One (2013) 0.97